Phesgo combination subcutaneous injection MA (Pertuzumab・Trastuzumab・Borhyaluronidase alpha), from Chugai Pharmaceutical (YJ code: 4291501A1028, standard: 10mL x 1 bottle), treats HER2-positive breast cancer. This fixed-dose combination, including pertuzumab and trastuzumab, is administered subcutaneously, with hyaluronidase facilitating absorption.
Phesgo combination subcutaneous injection MA
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).